A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
Public ClinicalTrials.gov record NCT03208985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Open-Label Trial Investigating Behavior Related to Ella® Use in a Simulated OTC Environment (LIBRella)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to assess whether consumers select and use ella® (ulipristal acetate 30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in an OTC-like setting.
Study identification
- NCT ID
- NCT03208985
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 23, 2017 (Actual)
- Primary completion
- Jun 14, 2018 (Actual)
- Completion
- Jun 14, 2018 (Actual)
- Last update posted
- Dec 2, 2022
2017 – 2018
United States locations
- U.S. sites
- 34
- U.S. states
- 13
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HRA Pharma Investigational Site | Rancho Cucamonga | California | 91730 | — |
| HRA Pharma Investigational Site | Boulder | Colorado | 80302 | — |
| HRA Pharma Investigational Site | Denver | Colorado | 80003 | — |
| HRA Pharma Investigational Site | Denver | Colorado | 80207 | — |
| HRA Pharma Investigational Site | Fort Myers | Florida | 33919 | — |
| HRA Pharma Investigational Site | Miami | Florida | 33133 | — |
| HRA Pharma Investigational Site | Orlando | Florida | 32817 | — |
| HRA Pharma Investigational Site | Pembroke Pines | Florida | 33026 | — |
| HRA Pharma Investigational Site | St. Petersburg | Florida | 33701 | — |
| HRA Pharma Investigational Site | Tampa | Florida | 33617 | — |
| HRA Pharma Investigational Site | Belleville | Illinois | 62226 | — |
| HRA Pharma Investigational Site | Andover | Minnesota | 55304 | — |
| HRA Pharma Investigational Site | Saint Louis Park | Minnesota | 55426 | — |
| HRA Pharma Investigational Site | City of Saint Peters | Missouri | 63376 | — |
| HRA Pharma Investigational Site | Kansas City | Missouri | 64111 | — |
| HRA Pharma Investigational Site | Manchester | Missouri | 63088 | — |
| HRA Pharma Investigational Site | St Louis | Missouri | 63108 | — |
| HRA Pharma Investigational Site | St Louis | Missouri | 63118 | — |
| HRA Pharma Investigational Site | Las Vegas | Nevada | 89102 | — |
| HRA Pharma Investigational Site | Hackensack | New Jersey | 07601 | — |
| HRA Pharma Investigational Site | Morristown | New Jersey | 07960 | — |
| HRA Pharma Investigational Site | New Brunswick | New Jersey | 08901 | — |
| HRA Pharma Investigational Site | Trenton | New Jersey | 08608 | — |
| HRA Pharma Investigational Site | Albuquerque | New Mexico | 87104 | — |
| HRA Pharma Investigational Site | Albuquerque | New Mexico | 87109 | — |
| HRA Pharma Investigational Site | New York | New York | 10012 | — |
| HRA Pharma Investigational Site | Durham | North Carolina | 27704 | — |
| HRA Pharma Investigational Site | Raleigh | North Carolina | 27603 | — |
| HRA Pharma Investigational Site | Portland | Oregon | 97212 | — |
| HRA Pharma Investigational Site | Bremerton | Washington | 98310 | — |
| HRA Pharma Investigational Site | Puyallup | Washington | 98373 | — |
| HRA Pharma Investigational Site | Seattle | Washington | 98122 | — |
| HRA Pharma Investigational Site | Seattle | Washington | 98133 | — |
| HRA Pharma Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03208985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03208985 live on ClinicalTrials.gov.